LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/VTI Partners With Medikon for Turkish Distribution
Spine

VTI Partners With Medikon for Turkish Distribution

May 11, 2017 1 min read Premium comments

Advertisement

VTI Partners With Medikon for Turkish Distribution
Photo creation by RRY Publications, LLC, VTI and Medikon
Secondary

Minneapolis, Minnesota-based VTI (Vertebral Technologies, Inc.) is announcing a partnership with the Turkish medical distribution company Medikon to distribute its InterFuse product line in Turkey.

“We are excited to start working with Medikon, the company has been serving the Turkish spine surgeon community since 1995 with highly differentiated products and I’m convinced they will do an excellent job selling the InterFuse product line,” said VTI’s Vice President of International Sales Ben Wasscher, in the May 4, 2017 news release.

Sinan Kazmaci, Managing Director of Medikon stated, “At Medikon we are excited to be working with the InterFuse modular cage. When we presented the product to our most important surgeons, there was a great deal of enthusiasm and excitement for the product. Surgeons thought that the modular approach to achieve a large footprint through a small access channel was a great idea and many of them are keen to start with InterFuse, especially for their more challenging patients.”

Ben Wasscher told OTW, “It is VTI’s objective to bring the benefits of the InterFuse modular cage, its large footprint and minimally invasive approach, to the largest number of patients. Turkey has a sizeable population and a well-developed health care sector. Our discussions with Turkish surgeons clearly demonstrated that they are certainly keen to use InterFuse with their patients.”

“Turkey is a country with around 80 million people. Initially the focus will be on the leading hospitals in Istanbul, but we anticipate expanding beyond that in the near future.”

Asked what might be challenging, he noted, “The reimbursement situation will certainly present challenges. But we are confident that together with our local partner Medikon, we can overcome these.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy